Literature DB >> 27460017

The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.

Chaoling Dong1, Steven P Palladino1, Eric Scott Helton1, Eroboghene E Ubogu2.   

Abstract

The molecular determinants and mechanisms involved in leukocyte trafficking across the blood-nerve barrier (BNB) in the acute inflammatory demyelinating polyradiculoneuropathy (AIDP) variant of Guillain-Barré syndrome are incompletely understood. Prior work using a flow-dependent in vitro human BNB model demonstrated a crucial role for αM-integrin (CD11b)-intercellular adhesion molecule-1 interactions in AIDP patient leukocyte trafficking. The aim of this study is to directly investigate the biological relevance of CD11b in AIDP pathogenesis. Immunohistochemistry was performed on three AIDP patient sural nerve biopsies to evaluate endoneurial leukocyte CD11b expression. A severe murine experimental autoimmune neuritis (sm-EAN) model was utilized to determine the functional role of CD11b in leukocyte trafficking in vivo and determine its effect on neurobehavioral measures of disease severity, electrophysiological assessments of axonal integrity and myelination and histopathological measures of peripheral nerve inflammatory demyelination. Time-lapse video microscopy and electron microscopy were employed to observe structural alterations at the BNB during AIDP patient leukocyte trafficking in vitro and in situ, respectively. Large clusters of endoneurial CD11b+ leukocytes associated with demyelinating axons were observed in AIDP patient sural nerves. Leukocyte CD11b expression was upregulated during sm-EAN. 5 mg/kg of a function-neutralizing monoclonal rat anti-mouse CD11b antibody administered after sm-EAN disease onset significantly ameliorated disease severity, as well as electrophysiological and histopathological parameters of inflammatory demyelination compared to vehicle- and isotype antibody-treated mice. Consistent with in vitro observations of leukocyte trafficking at the BNB, electron micrographs of AIDP patient sural nerves demonstrated intact electron-dense endoneurial microvascular intercellular junctions during paracellular mononuclear leukocyte transmigration. Our data support a crucial pathogenic role of CD11b in AIDP leukocyte trafficking, providing a potential therapeutic target for demyelinating variants of Guillain-Barré syndrome.

Entities:  

Keywords:  Acute inflammatory demyelinating polyradiculoneuropathy; Blood–nerve barrier; CD11b; Experimental autoimmune neuritis; Guillain–Barré syndrome; Integrin

Mesh:

Substances:

Year:  2016        PMID: 27460017      PMCID: PMC5074851          DOI: 10.1007/s00401-016-1599-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  41 in total

1.  Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain-Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood.

Authors:  A Créange; B Chazaud; T Sharshar; A Plonquet; F Poron; M C Eliezer; J C Raphaël; R K Gherardi
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

2.  A rapid, simple, and humane method for submandibular bleeding of mice using a lancet.

Authors:  William T Golde; Peter Gollobin; Luis L Rodriguez
Journal:  Lab Anim (NY)       Date:  2005-10       Impact factor: 12.625

3.  Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells.

Authors:  Nejla Yosef; Robin H Xia; Eroboghene E Ubogu
Journal:  J Neuropathol Exp Neurol       Date:  2010-01       Impact factor: 3.685

4.  Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier.

Authors:  Ryan C Winger; Jennifer E Koblinski; Takashi Kanda; Richard M Ransohoff; William A Muller
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

Review 5.  Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.

Authors:  Takashi Kanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-13       Impact factor: 10.154

6.  Chemokine-dependent signaling pathways in the peripheral nervous system.

Authors:  Eroboghene E Ubogu
Journal:  Methods Mol Biol       Date:  2013

7.  α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.

Authors:  Nejla Yosef; Eroboghene E Ubogu
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

8.  Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.

Authors:  Eroboghene E Ubogu; Melissa K Callahan; Barbara H Tucky; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2006-07-20       Impact factor: 3.478

9.  Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  D Orlikowski; B Chazaud; A Plonquet; F Poron; T Sharshar; P Maison; J-C Raphaël; R K Gherardi; A Créange
Journal:  J Neuroimmunol       Date:  2003-01       Impact factor: 3.478

Review 10.  Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation.

Authors:  Kelsey M Greathouse; Steven P Palladino; Chaoling Dong; Eric S Helton; Eroboghene E Ubogu
Journal:  J Neuroinflammation       Date:  2016-01-06       Impact factor: 8.322

View more
  13 in total

1.  Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Chaoling Dong; Kelsey M Greathouse; Rebecca L Beacham; Steven P Palladino; E Scott Helton; Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2017-02-16       Impact factor: 5.330

Review 2.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

3.  In situ molecular characterization of endoneurial microvessels that form the blood-nerve barrier in normal human adult peripheral nerves.

Authors:  Xuan Ouyang; Chaoling Dong; Eroboghene E Ubogu
Journal:  J Peripher Nerv Syst       Date:  2019-06-04       Impact factor: 3.494

4.  GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways.

Authors:  Chaoling Dong; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-12-07

5.  Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy.

Authors:  Chaoling Dong; E Scott Helton; Ping Zhou; Xuan Ouyang; Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-09-05

6.  Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease.

Authors:  John W McLean; Julie A Wilson; Tina Tian; Jennifer A Watson; Mary VanHart; Andrew J Bean; Steven S Scherer; David K Crossman; Eroboghene Ubogu; Scott M Wilson
Journal:  J Neurosci       Date:  2022-05-19       Impact factor: 6.709

Review 7.  Biology of the human blood-nerve barrier in health and disease.

Authors:  Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2020-03-03       Impact factor: 5.330

8.  The Human Blood-Nerve Barrier Transcriptome.

Authors:  Steven P Palladino; E Scott Helton; Preti Jain; Chaoling Dong; Michael R Crowley; David K Crossman; Eroboghene E Ubogu
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 9.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

10.  Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.

Authors:  Björn Ambrosius; Kalliopi Pitarokoili; Lisa Schrewe; Xiomara Pedreiturria; Jeremias Motte; Ralf Gold
Journal:  J Neuroinflammation       Date:  2017-04-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.